Virtu Financial LLC Lexaria Bioscience Corp. Transaction History

Virtu Financial LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 09, 2022	SELL	$1.88 - $4.06 $1,975 - $4,267	-1,051 Reduced 8.74%	10,975 $33,000
Q1 2022 May 17, 2022	BUY	$2.78 - $4.7 $33,432 - $56,522	12,026 New	12,026 $40,000
Q4 2021 Feb 17, 2022	SELL	$3.87 - $6.9 $46,211 - $82,392	-11,941 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$5.39 - $8.44 $64,361 - $100,782	11,941 New	11,941 $75,000

2.06M

Ticker LEXX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 5,951,000
Market Cap $18M
Description
Lexaria Bioscience Corp. operates as a biotechnology company. Its patented drug delivery technology, DehydraTECH, improves the way active pharmaceutical ingredients enter the bloodstream by promoting effective oral delivery. The company's DehydraTECH has demonstrated the ability to increase bio-absorption with cannabinoids and nicotine by 5-10x ...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.